GenVec Ditches Liquidation Plan For Novartis Partnership
Flagging biotech firm GenVec Inc. has scrapped plans to dissolve and liquidate assets amid encouraging prospects for a program to develop new hearing loss treatments in partnership with Novartis AG and...To view the full article, register now.
Already a subscriber? Click here to view full article